Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

large-cell immunoblastic lymphoma - Clinical Profile, Genes & Research | Kisho | Kisho

9 clinical trials registered, 4 recruiting. Interventions under study include other interventions, procedural interventions, drug therapy, and medical devices. Pipeline includes 1 PHASE2, 3 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT05663502](https://clinicaltrials.gov/study/NCT05663502)	Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers	—	AIDS Malignancy Consortium	RECRUITING
[NCT01199562](https://clinicaltrials.gov/study/NCT01199562)	Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant	—	City of Hope Medical Center	ACTIVE_NOT_RECRUITING
[NCT01137643](https://clinicaltrials.gov/study/NCT01137643)	Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer	—	UNC Lineberger Comprehensive Cancer Center	RECRUITING
[NCT01815749](https://clinicaltrials.gov/study/NCT01815749)	Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma	PHASE1	City of Hope Medical Center	ACTIVE_NOT_RECRUITING
[NCT00544115](https://clinicaltrials.gov/study/NCT00544115)	Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders	PHASE2	City of Hope Medical Center	ACTIVE_NOT_RECRUITING

5 publications have been identified in PubMed for large-cell immunoblastic lymphoma. Research spans Review / Meta-Analysis (60%) and Case Report / Case Series (40%).

Recent Publications

Rangoonwala HI (2026). [PMID: 32965972](https://pubmed.ncbi.nlm.nih.gov/32965972/). *Unknown Journal*. [Review / Meta-Analysis]
Chen BJ (2026). [PMID: 42108217](https://pubmed.ncbi.nlm.nih.gov/42108217/). *J Cutan Pathol*. [Case Report / Case Series]
Zanelli M (2025). [PMID: 40869163](https://pubmed.ncbi.nlm.nih.gov/40869163/). *Int J Mol Sci*. [Review / Meta-Analysis]
Będkowska D (2025). [PMID: 40002191](https://pubmed.ncbi.nlm.nih.gov/40002191/). *Cancers (Basel)*. [Review / Meta-Analysis]
S SS (2024). [PMID: 39651017](https://pubmed.ncbi.nlm.nih.gov/39651017/). *Cureus*. [Case Report / Case Series]

Kisho

large-cell immunoblastic lymphoma

Overview

Research Landscape

Recent Publications

Medical References

External Resources

GARD

Questions for Your Care Team

Questions for Your Care Team

large-cell immunoblastic lymphoma

Overview

Research Landscape

Recent Publications

Medical References

External Resources

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team